Showing results (91-100 of 259) with videos related to
Sort By:
Pageof 26
Blood|May 5, 2016
HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinibGuang Yang, Sara J Buhrlage, Li Tan, et al.British Journal of Haematology|September 6, 2018
TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenström macroglobulinaemiaJoshua N Gustine, Nicholas Tsakmaklis, Maria G Demos, et al.Leukemia & Lymphoma|January 30, 2020
A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemiaJorge J Castillo, Gilad Itchaki, Joshua N Gustine, et al.Blood Advances|January 15, 2020
Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomasXia Liu, Jiaji G Chen, Manit Munshi, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|November 15, 2006
Hyperviscosity-related retinopathy in waldenstrom macroglobulinemiaMarcel N Menke, Gilbert T Feke, J Wallace McMeel, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 8, 2001
Tumor Cell Expression of CD59 Is Associated With Resistance to CD20 Serotherapy in Patients With B-Cell MalignanciesSteven P. Treon, Constantine Mitsiades, Nicholas Mitsiades, et al.Blood|November 16, 2023
Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-naïve Waldenström macroglobulinemiaJorge J Castillo, Andrew R Branagan, David Sermer, et al.Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Histone deacetylase inhibitors demonstrate significant preclinical activity as single agents, and in combination with bortezomib in Waldenström's macroglobulinemiaJenny Y Sun, Lian Xu, Hsuyi Tseng, et al.British Journal of Haematology|November 29, 2017
MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survivalSteven P Treon, Joshua Gustine, Lian Xu, et al.Seminars in Oncology|April 30, 2003
The malignant clone in Waldenstrom's macroglobulinemiaJitra Kriangkum, Brian J Taylor, Michael J Mant, et al.Pageof 26